Cannara Biotech Stock Market Value
| LOVFF Stock | USD 0.52 0.09 20.93% |
| Symbol | Cannara |
Cannara Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cannara Biotech's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cannara Biotech.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Cannara Biotech on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Cannara Biotech or generate 0.0% return on investment in Cannara Biotech over 30 days. Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabi... More
Cannara Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cannara Biotech's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cannara Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 36.67 | |||
| Value At Risk | (6.90) | |||
| Potential Upside | 7.41 |
Cannara Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cannara Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cannara Biotech's standard deviation. In reality, there are many statistical measures that can use Cannara Biotech historical prices to predict the future Cannara Biotech's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (1.06) | |||
| Treynor Ratio | 0.1433 |
Cannara Biotech Backtested Returns
Cannara Biotech secures Sharpe Ratio (or Efficiency) of -6.0E-4, which signifies that the company had a -6.0E-4% return per unit of risk over the last 3 months. Cannara Biotech exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cannara Biotech's Mean Deviation of 2.26, risk adjusted performance of (0.03), and Standard Deviation of 5.13 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -1.73, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Cannara Biotech are expected to decrease by larger amounts. On the other hand, during market turmoil, Cannara Biotech is expected to outperform it. At this point, Cannara Biotech has a negative expected return of -0.0036%. Please make sure to confirm Cannara Biotech's potential upside, as well as the relationship between the daily balance of power and price action indicator , to decide if Cannara Biotech performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.38 |
Poor reverse predictability
Cannara Biotech has poor reverse predictability. Overlapping area represents the amount of predictability between Cannara Biotech time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cannara Biotech price movement. The serial correlation of -0.38 indicates that just about 38.0% of current Cannara Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.38 | |
| Spearman Rank Test | -0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Cannara Biotech lagged returns against current returns
Autocorrelation, which is Cannara Biotech otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cannara Biotech's otc stock expected returns. We can calculate the autocorrelation of Cannara Biotech returns to help us make a trade decision. For example, suppose you find that Cannara Biotech has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cannara Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cannara Biotech otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cannara Biotech otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cannara Biotech otc stock over time.
Current vs Lagged Prices |
| Timeline |
Cannara Biotech Lagged Returns
When evaluating Cannara Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cannara Biotech otc stock have on its future price. Cannara Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cannara Biotech autocorrelation shows the relationship between Cannara Biotech otc stock current value and its past values and can show if there is a momentum factor associated with investing in Cannara Biotech.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Cannara OTC Stock
Cannara Biotech financial ratios help investors to determine whether Cannara OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cannara with respect to the benefits of owning Cannara Biotech security.